Search

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 860.95 9.50  | 1.12% -9.44% 33.70 24,267.87
NSE Price: Jul 29, 2016 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Jul 29, 2016 860.95 9.50 1.12% 857.85 851.45 452,246 851.25 - 864.75
BSE Jul 29, 2016 860.05 7.00 0.82% 853.00 853.05 26,704 852.45 - 864.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 660,047 P/B: 7.94 NSE Code: GLENMARK
52-Week Range: R 671.10 - 1,262.90 Dividend Yield: 0.23% BSE Code: 532296
TTM EPS: R 25.52 Book Value: R 108.32 Face Value: R 1
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. -6.61 8.66 3.80 -9.44 13.58 21.08 18.49
S&P BSE Sensex 7.41 3.90 9.55 -0.22 13.20 9.03 10.07
S&P BSE Healthcare -3.58 5.20 4.60 -4.39 21.58 20.46 17.57
Company's return has been calculated on basis of NSE's price.
As on Jul 29, 2016
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 15.55 15.82 21.22
Net Profit 243.67 4.64 9.47
EPS 230.41 3.69 8.76
Book Value 64.77 2.02 7.52
Average
Operating Margin 18.83 18.55 18.90
Net Margin 9.30 7.20 9.14
Return on Networth 29.75 19.18 20.56
Return on Investment 19.04 15.49 15.72
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 29.88 28.46 28.46
Operating Profit -15.48 11.57 11.57
Net Profit 0.79 1,518.26 1,518.26
EPS 0.91 1,453.58 1,453.58
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 24,267.87 6,113.50 1,468.43 23.57 29.75 7.94 33.70
Lupin 78,504.53 14,208.47 2,279.45 15.81 23.05 7.16 34.57
Sun Pharmaceutical Inds. 199,700.41 7,612.40 -1,073.36 -13.68 24.89 6.36 42.35
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 12,200 707.70 86.34
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 20,000 707.70 141.54
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 1,500 765.30 11.48
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 17,980 765.30 137.60
Sep 01, 2014 Blanche Elizabeth Saldanha  Buy Market 27,758 720.45 199.98
Fund Houses invested in the stock
Fund Jun-16 Mar-16 Dec-15 Sep-15 Jun-15
Tata Mutual Fund 0.697 0.733 - 0.642 0.546
Sundaram Mutual Fund 0.256 0.256 0.256 0.214 0.193
SBI Mutual Fund 0.229 0.221 0.195 0.008 0.121
HDFC Mutual Fund 0.117 0.101 0.114 0.074 0.074
Kotak Mahindra Mutual Fund 0.098 0.040 0.101 0.115 0.085
HSBC Mutual Fund 0.087 0.119 0.085 0.093 0.187
IDFC Mutual Fund 0.049 0.061 0.056 0.245 0.353
ICICI Prudential Mutual Fund 0.025 0.003 0.013 0.012 0.003
UTI Mutual Fund 0.014 - - 0.052 0.040
Edelweiss Mutual Fund 0.012 - - - 0.010
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: [email protected]

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
3.82
Piotroski F-Score
7
Modified C-Score
2
5-Years Price to Earnings
33.70
5-Years Price to Book
7.94
Earnings Yield
EBIT / Enterprise value
1.76%
PEG
Price / Earnings to growth ratio
2.07
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R791.45 +1.56%
Cadila Healthcare R366.90 +1.41%
Cipla R527.40 +1.30%
Divi's Laboratories R1,198.50 +0.25%
Dr. Reddy's Lab R2,935.35 -0.82%
Glaxosmithkline Pharma R3,314.95 -0.94%
Lupin R1,739.85 +2.05%
Piramal Enterprises R1,607.05 -0.10%
Sun Pharmaceutical Inds. R829.95 +0.55%
Torrent Pharmaceuticals R1,440.45 +0.24%
As on Jul 29, 2016